Competition Twists Line Between Marketing Drugs, Cosmetics – Attorney
This article was originally published in The Tan Sheet
Executive Summary
The line dividing drugs from personal care products is "fuzzy," but assessing the mistakes of other firms is a clear way to understand what marketing claims FDA will accept, according to attorney Ivan Wasserman